title: Characterization of streptococcal platelet-activating factor acetylhydrolase variants that are involved in innate immune evasion.
abstract: Human pathogen group A streptococcus (GAS) has developed mechanisms to subvert innate immunity. We recently reported that the secreted esterase produced by serotype M1 GAS (SsE(M1)) reduces neutrophil recruitment by targeting platelet-activating factor (PAF). SsE(M1) and SsE produced by serotype M28 GAS (SsE(M28)) have a 37% sequence difference. This study aims at determining whether SsE(M28) is also a PAF acetylhydrolase and participates in innate immune evasion. We also examined whether SsE evolved to target PAF by characterizing the PAF acetylhydrolase (PAF-AH) activity and substrate specificity of SsE(M1), SsE(M28), SeE, the SsE homologue in Streptococcus equi, and human plasma PAF-AH (hpPAF-AH). PAF incubated with SsE(M28) or SeE was converted into lyso-PAF. SsE(M1) and SsE(M28) had kcat values of 373 s(-1) and 467 s(-1), respectively, that were ≥ 30-fold greater than that of hpPAF-AH (12 s(-1)). The comparison of SsE(M1), SsE(M28), and hpPAF-AH in kcat and Km in hydrolyzing triglycerides, acetyl esters, and PAF indicates that the SsE proteins are more potent hydrolases against PAF and have high affinity for PAF. SsE(M28) possesses much lower esterase activities against triglycerides and other esters than SsE(M1) but have similar potency with SsE(M1) in PAF hydrolysis. Deletion of sse(M28) in a covS deletion mutant of GAS increased neutrophil recruitment and reduced skin infection, whereas in trans expression of SsE(M28) in GAS reduced neutrophil infiltration and increased skin invasion in subcutaneous infection of mice. These results suggest that the SsE proteins evolved to target PAF for enhancing innate immune evasion and skin invasion.
authors.affiliation: Department of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, USA.
authors.forename: Guanghui
authors.initials: G
authors.lastname: Liu
authors.forename: Mengyao
authors.initials: M
authors.lastname: Liu
authors.forename: Gang
authors.initials: G
authors.lastname: Xie
authors.forename: Benfang
authors.initials: B
authors.lastname: Lei
mesh_terms: D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D004950:Esterases / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D005260:Female; D006801:Humans; D006868:Hydrolysis; D057131:Immune Evasion / Q000235:genetics / Q000276:immunology*; D007113:Immunity, Innate / Q000235:genetics / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D020556:Neutrophil Infiltration / Q000235:genetics / Q000276:immunology; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D010972:Platelet Activating Factor / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D017384:Sequence Deletion / Q000235:genetics / Q000276:immunology; D013207:Staphylococcal Skin Infections / Q000235:genetics / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D013291:Streptococcus / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D013379:Substrate Specificity / Q000235:genetics / Q000276:immunology; D014280:Triglycerides / Q000235:genetics / Q000276:immunology / Q000378:metabolism
chemical_list: D010972:Platelet Activating Factor; D014280:Triglycerides; D004950:Esterases; D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase